login
Become a member
Quick Registration
Full Registration Benefits -
Free Homepages for Doctors
Free Homepages for Hospitals
Free Homepages for Medical Conference
Free Homepages for NGO's
Personal Health Record Creation
Access to all Medical Slides
Access to all Jobs & Products Sale
FDA Approves Abbott’s Xience Prime Coronary Stent
Abbott said that the stent, known as Xience Prime, is similar to its predecessor Xience V as it uses the same drug and biocompatible polymer but the company added that Xience Prime offers thinner struts which help it to maintain radial strength and thus offer better delivery.
Confirming the approval of the stent, the FDA said that its decision was based on the SPIRIT PRIME trial which tested the effectiveness of the stent in 500 patients with coronary artery disease.
The FDA revealed that the stent showed lower rates of target lesion failure and stent thrombosis at the end of one year.
Source-Medindia
|
|
 Comment & Contribute
|
Medwonders Health Network
- Health News Index
|
|
- News Quick Links
| News Categories: |
| » | Report: A Lot of Americans Have No Access to Health Care |
| » | Greece Faces Humanitarian Crisis as Health Care Access Declines in EU, Doctors Group Warns |
| » | HCCI Report Says Rising Prices for Care Responsible for Increased Healthcare Costs for Privately Insured Americans |
| » | Treatment in ED is Based on Children's Insurance Status |
| » | US Spends Most on Healthcare Without Providing Superior Care |
| More Insurance News | |
|
